CBT
AMGN icon

Central Bank & Trust’s Amgen AMGN Stock Holding History

Central Bank & Trust’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.84M Sell
16,134
-7,652
-32% -$2.62M 0.83% 30
2026
Q1 		$8.37M Sell
23,786
-589
-2% -$210K 1.32% 21
2025
Q4 		$7.98M Sell
24,375
-185
-0.8% -$58.7K 1.23% 24
2025
Q3 		$6.93M Buy
24,560
+16
+0.1% +$4.64K 1.09% 26
2025
Q2 		$6.85M Sell
24,544
-217
-0.9% -$61.5K 1.12% 29
2025
Q1 		$7.71M Sell
24,761
-2,160
-8% -$638K 1.29% 22
2024
Q4 		$7.02M Sell
26,921
-594
-2% -$176K 1.06% 30
2024
Q3 		$8.87M Sell
27,515
-2,623
-9% -$858K 1.22% 26
2024
Q2 		$9.42M Buy
30,138
+1,223
+4% +$359K 1.31% 24
2024
Q1 		$8.22M Buy
28,915
+400
+1% +$117K 1.17% 31
2023
Q4 		$8.21M Buy
28,515
+1,759
+7% +$479K 1.27% 25
2023
Q3 		$7.19M Sell
26,756
-237
-0.9% -$59.1K 1.25% 28
2023
Q2 		$5.99M Sell
26,993
-747
-3% -$173K 1.02% 37
2023
Q1 		$6.71M Buy
27,740
+313
+1% +$76.8K 1.19% 30
2022
Q4 		$7.2M Sell
27,427
-596
-2% -$160K 1.36% 23
2022
Q3 		$6.32M Sell
28,023
-923
-3% -$224K 1.36% 25
2022
Q2 		$7.04M Buy
28,946
+135
+0.5% +$33.1K 1.44% 22
2022
Q1 		$6.97M Sell
28,811
-628
-2% -$144K 1.11% 32
2021
Q4 		$6.62M Buy
29,439
+25
+0.1% +$5.28K 1.02% 34
2021
Q3 		$6.25M Buy
29,414
+1,120
+4% +$258K 1.03% 32
2021
Q2 		$6.9M Buy
28,294
+764
+3% +$188K 1.11% 30
2021
Q1 		$6.85M Buy
27,530
+94
+0.3% +$22.4K 1.17% 30
2020
Q4 		$6.31M Buy
27,436
+162
+0.6% +$37.4K 1.09% 31
2020
Q3 		$6.93M Sell
27,274
-792
-3% -$196K 1.3% 21
2020
Q2 		$6.62M Sell
28,066
-950
-3% -$217K 1.31% 18
2020
Q1 		$5.88M Sell
29,016
-648
-2% -$142K 1.42% 18
2019
Q4 		$7.15M Sell
29,664
-2,190
-7% -$483K 1.41% 19
2019
Q3 		$6.16M Sell
31,854
-492
-2% -$94.4K 1.33% 22
2019
Q2 		$5.96M Sell
32,346
-3,695
-10% -$662K 1.34% 21
2019
Q1 		$6.85M Buy
36,041
+1,024
+3% +$196K 1.54% 16
2018
Q4 		$6.82M Sell
35,017
-390
-1% -$76.1K 1.72% 14
2018
Q3 		$7.34M Buy
35,407
+1,097
+3% +$216K 1.7% 18
2018
Q2 		$6.33M Buy
34,310
+5,973
+21% +$1.06M 1.58% 23
2018
Q1 		$4.83M Buy
28,337
+16,745
+144% +$3.07M 1.21% 36
2017
Q4 		$2.02M Buy
11,592
+802
+7% +$142K 0.49% 64
2017
Q3 		$2.01M Sell
10,790
-61
-0.6% -$10.8K 0.5% 61
2017
Q2 		$1.87M Sell
10,851
-327
-3% -$53.2K 0.49% 61
2017
Q1 		$1.83M Sell
11,178
-281
-2% -$46.7K 0.47% 62
2016
Q4 		$1.68M Sell
11,459
-361
-3% -$54.3K 0.45% 67
2016
Q3 		$1.97M Sell
11,820
-283
-2% -$47.9K 0.55% 59
2016
Q2 		$1.84M Sell
12,103
-92
-0.8% -$14.3K 0.53% 58
2016
Q1 		$1.83M Sell
12,195
-1,445
-11% -$215K 0.51% 59
2015
Q4 		$2.21M Sell
13,640
-1,025
-7% -$161K 0.64% 54
2015
Q3 		$2.03M Buy
14,665
+1,057
+8% +$167K 0.67% 47
2015
Q2 		$2.09M Buy
13,608
+1,011
+8% +$162K 0.66% 52
2015
Q1 		$2.01M Buy
12,597
+852
+7% +$134K 0.67% 49
2014
Q4 		$1.87M Sell
11,745
-503
-4% -$78.4K 0.64% 51
2014
Q3 		$1.72M Buy
12,248
+1,367
+13% +$178K 0.65% 55
2014
Q2 		$1.24M Sell
10,881
-692
-6% -$80.1K 0.48% 64
2014
Q1 		$1.43M Buy
11,573
+692
+6% +$83.9K 0.56% 63
2013
Q4 		$1.24M Buy
10,881
+3,382
+45% +$385K 0.48% 64
2013
Q3 		$839K Buy
7,499
+6,299
+525% +$683K 0.38% 76
2013
Q2 		$119K Buy
+1,200
New +$125K 0.06% 142

Other funds holding AMGN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Central Bank & Trust's AMGN Position: Q2 2026 in Review

Central Bank & Trust reduced its Amgen (AMGN) stake by 32% in Q2 2026, selling an estimated $2.62M and leaving 16,134 shares worth $5.84M. The position accounts for 0.83% of the portfolio, ranked #30.

Central Bank & Trust first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.42M in Q2 2024. 659 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Central Bank & Trust held 16,134 shares of Amgen worth $5.84M as of Q2 2026.
  • Central Bank & Trust sold 7,652 Amgen shares in Q2 2026, an estimated $2.62M.
  • Amgen made up 0.83% of Central Bank & Trust's portfolio in Q2 2026, its #30 holding.
  • Central Bank & Trust first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Central Bank & Trust's Amgen position peaked at $9.42M in Q2 2024.
  • 659 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Central Bank & Trust's 13F filing for Q2 2026, filed 17 Jul 2026.